1
Clinical Trials associated with Allo iPS cell-derived dopamine neural progenitors(Kyoto University)Kyoto Trial to Evaluate the Safety and Efficacy of iPSC-derived dopaminergic progenitors in the treatment of Parkinson's Disease - Kyoto Trial to Evaluate the Safety and Efficacy of iPSC-derived dopaminergic progenitors in the treatment of Parkinson's Disease
100 Clinical Results associated with Allo iPS cell-derived dopamine neural progenitors(Kyoto University)
100 Translational Medicine associated with Allo iPS cell-derived dopamine neural progenitors(Kyoto University)
100 Patents (Medical) associated with Allo iPS cell-derived dopamine neural progenitors(Kyoto University)
100 Deals associated with Allo iPS cell-derived dopamine neural progenitors(Kyoto University)